Nebius Earnings Preview: $643M Eigen Acquisition Aims to Boost Inference, But DeepValue Report Flags Execution and Dilution Risks

What happened

Nebius spent $643M on Eigen to enhance its Token Factory inference platform ahead of Q1 earnings, where consensus expects $388.6M revenue (600% YoY growth) but continued losses. However, the DeepValue report rates NBIS a 'POTENTIAL SELL', warning that Meta's $12B dedicated compute doesn't start until early 2027, while FY2025 capex was $4.07B and dilution from converts could reach ~66M shares. The report also notes the NVIDIA deal is a pre-funded warrant, not a GPU allocation, and that insider sales clustered in late March/early April. The Eigen acquisition may improve inference efficiency, but it does not address the core capacity-to-revenue conversion timeline or the financing overhang. Essentially, the earnings preview highlights a near-term catalyst, but the DeepValue analysis underscores structural risks from delayed revenue, extreme capex, and potential dilution.

Implication

Investors should weigh the Eigen-driven efficiency gains against the DeepValue report's severe warnings: the stock prices in a capacity ramp that filings push to early 2027 for the Meta tranche, with further dilution possible. The Q1 earnings beat may provide a short-term catalyst, but the structural risks of timeliness, execution, and capital structure persist. We see no margin of safety at current levels and recommend trimming above $165 as per DeepValue's trim trigger.

Thesis delta

The DeepValue report shifts the thesis from a 'capacity-to-revenue conversion' narrative to a 'dilution and timing risk' framework. While the Eigen acquisition incrementally improves the inference layer, it does not change the fundamental issue that NBIS's equity value depends on proving 2026 connected-power ramp and third-party fill before the Meta stream starts in 2027. The report's POTENTIAL SELL rating and trim above $165 contrast with the earnings preview's bullish stance, reinforcing a cautious view.